Pathogenesis and medical management of benign prostatic hyperplasia

Research output: Contribution to journalShort surveypeer-review

7 Scopus citations


Benign prostatic hyperplasia is an almost universal disorder of aging males. The disease is heterogeneous with respect to the histology, size, symptoms, and response to medical management. Current medical therapies are based upon the knowledge of the pathophysiology of the disease and include hormonal therapies and α1-adrenergic blockade. Although there are at present no prognostic indicators of response to therapy, future studies may help delineate those patients who will most benefit from the various forms of treatment.

Original languageEnglish
Pages (from-to)128-132
Number of pages5
JournalTrends in Endocrinology and Metabolism
Issue number4
StatePublished - 1995


Dive into the research topics of 'Pathogenesis and medical management of benign prostatic hyperplasia'. Together they form a unique fingerprint.

Cite this